Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft
Frans Beerkens(Icahn School of Medicine at Mount Sinai), Annapoorna Kini(Mount Sinai Medical Center), Samantha Sartori(Icahn School of Medicine at Mount Sinai), Carlo Andrea Pivato(Cardiovascular Institute of the South), Samin K. Sharma(Mount Sinai Health System), Matteo Nardin(Humanitas University), David Power(Cardiovascular Institute of the South), Anne H. Tavenier(Cardiovascular Institute of the South), Ranbir Singh(Mount Sinai Hospital), Gennaro Giustino(Cardiovascular Institute of the South), Davis Jones(Cardiovascular Institute of the South), George Dangas(Mount Sinai Hospital), Nitin Barman(Icahn School of Medicine at Mount Sinai), Victor Razuk(Mount Sinai Hospital), Prakash Krishnan(Mount Sinai Hospital), Anton Camaj(Columbia University Irving Medical Center), Joseph Sweeny(Mount Sinai Hospital), Clayton Snyder(Cardiovascular Institute of the South), Usman Baber(Icahn School of Medicine at Mount Sinai), Johny Nicolas(Cardiovascular Institute of the South), Mauro Chiarito(Humanitas University), Davide Cao(Cardiovascular Institute of the South), Roxana Mehran(Mount Sinai Hospital), Bimmer E. Claessen(Columbia University Irving Medical Center)
Cited by 5
Related Papers
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
|New England Journal of Medicine|2016|1.5k
Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI
|Journal of the American College of Cardiology|2016|438
Characterization of Myocardial Injury in Patients With COVID-19
|Journal of the American College of Cardiology|2020|429